In Europe, the authors of this new study suggest, some patent barriers may be more illusory than real.
Deana Ferreri
Advertisement
Articles by Deana Ferreri
Advertisement
Latest Updated Articles
Secondary Patents Not an Issue for Biosimilars in Europe, Study NotesPublished: May 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx
3
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
4
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
5
